Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now owns 96,343 shares of the company’s stock, […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now directly owns 96,343 shares of […]
Quest Diagnostics Inc (NYSE:DGX) recently announced a dividend of $0.75 per share, payable on 2024-04-22, with the ex-dividend date set for 2024-04-05. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Quest Diagnostics Inc's dividend performance and assess its sustainability.
/PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, and DELFI Diagnostics, Inc., a developer of...
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.